KV Pharmaceutical Moves To Toss Securities Action
KV Pharmaceutical Co. has asked a federal court to dismiss a consolidated securities class action arising from alleged financial misstatements and widespread drug recalls, calling the litigation nothing more than "fraud...To view the full article, register now.
Already a subscriber? Click here to view full article